- £82.35m
- £91.41m
- £1.69m
Holding(s) in Company
Holding(s) in Company
Holding(s) in Company
Brief: 4Basebio HY Loss For Period Of £2.4 Million
Second Price Monitoring Extn
Price Monitoring Extension
Brief: 4Basebio Says Working With Universities To Develop Treatment For Neurofibromatosis Type 1
Price Monitoring Extension
Second Price Monitoring Extn
Price Monitoring Extension
Second Price Monitoring Extn
Price Monitoring Extension
Price Monitoring Extension
Price Monitoring Extension
Second Price Monitoring Extn
Price Monitoring Extension
Second Price Monitoring Extn
Price Monitoring Extension
4Basebio UK Societas - Second Price Monitoring Extn